Natalie Mount is the founder of Cytospire Therapeutics. Cytospire Therapeutics has raised $83M in total funding. Latest round: Series A. Backed by Abingworth.
Natalie Mount is the co-founder and CEO of Cytospire Therapeutics, a UK-based biotech company focused on developing multispecific immune cell engager antibodies for cancer. Cytospire Therapeutics secured an oversubscribed £61 million ($83 million) Series A funding round in May 2026. She previously joined Abingworth as a venture partner, which subsequently led Cytospire's seed round.
Full founder directory · Investor directory · Company funding database · Fundraising library